Western University

Scholarship@Western
Bone and Joint Institute
6-15-2016

Outcomes of unilateral and bilateral total knee arthroplasty in
238,373 patients
Eric R. Bohm
University of Manitoba

Katy Molodianovitsh
Institut canadien d'information sur la santé

Alina Dragan
Institut canadien d'information sur la santé

Naisu Zhu
Institut canadien d'information sur la santé

Greg Webster
Institut canadien d'information sur la santé

See next page for additional authors

Follow this and additional works at: https://ir.lib.uwo.ca/boneandjointpub
Part of the Medicine and Health Sciences Commons

Citation of this paper:
Bohm, Eric R.; Molodianovitsh, Katy; Dragan, Alina; Zhu, Naisu; Webster, Greg; Masri, Bas; Schemitsch,
Emil; and Dunbar, Michael, "Outcomes of unilateral and bilateral total knee arthroplasty in 238,373
patients" (2016). Bone and Joint Institute. 1133.
https://ir.lib.uwo.ca/boneandjointpub/1133

Authors
Eric R. Bohm, Katy Molodianovitsh, Alina Dragan, Naisu Zhu, Greg Webster, Bas Masri, Emil Schemitsch,
and Michael Dunbar

This article is available at Scholarship@Western: https://ir.lib.uwo.ca/boneandjointpub/1133

Acta Orthopaedica

ISSN: 1745-3674 (Print) 1745-3682 (Online) Journal homepage: https://www.tandfonline.com/loi/iort20

Outcomes of unilateral and bilateral total knee
arthroplasty in 238,373 patients
Eric R Bohm, Katy Molodianovitsh, Alina Dragan, Naisu Zhu, Greg Webster,
Bas Masri, Emil Schemitsch & Michael Dunbar
To cite this article: Eric R Bohm, Katy Molodianovitsh, Alina Dragan, Naisu Zhu, Greg
Webster, Bas Masri, Emil Schemitsch & Michael Dunbar (2016) Outcomes of unilateral and
bilateral total knee arthroplasty in 238,373 patients, Acta Orthopaedica, 87:sup1, 24-30, DOI:
10.1080/17453674.2016.1181817
To link to this article: https://doi.org/10.1080/17453674.2016.1181817

© 2016 The Author(s). Published by Taylor &
Francis on behalf of the Nordic Orthopedic
Federation.
Published online: 11 May 2016.

Submit your article to this journal

Article views: 2262

View related articles

View Crossmark data

Citing articles: 27 View citing articles

Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=iort20

24

Acta Orthopaedica 2016; 87 (eSuppl 362): 24–30

Electronic Supplementum no 362: ISAR meeting Gothenburg 2015, Sweden
Peer-reviewed article based on study presented at the 2015 meeting of the International Congress of
Arthroplasty Registries

Outcomes of unilateral and bilateral total knee arthroplasty in
238,373 patients
Eric R BOHM 1,2, Katy MOLODIANOVITSH 2, Alina DRAGAN 2, Naisu ZHU 2, Greg WEBSTER 2, Bas MASRI 3, Emil
SCHEMITSCH 4, and Michael DUNBAR 2,5

1 Department

of Surgery, University of Manitoba, Winnipeg, Manitoba; 2 Canadian Institute for Health Information, Ottawa, Ontario; 3 Department of
Orthopaedic Surgery, University of British Columbia, Vancouver, British Columbia; 4 Department of Surgery, University of Toronto, Toronto, Ontario;
5 Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada.
Correspondence: ebohm@cjrg.ca
Submitted 2015-08-02. Accepted 2016-01-29.

Background and purpose — There is no consensus about the outcome of simultaneous vs. staged bilateral total knee arthroplasty
(TKA). We examined this issue by analyzing 238,373 patients.
Patients and methods — Demographic, clinical, and outcome
data were evaluated for TKA patients (unilateral: 206,771; simultaneous bilateral: 6,349; staged bilateral: 25,253) from the Canadian Hospital Morbidity Database for fiscal years 2006–2007 to
2012–2013. Outcomes were adjusted for age, sex, comorbidities,
and hospital TKA volume.
Results — Simultaneous bilateral TKA patients were younger
than staged bilateral TKA patients (median 64 years vs. 66 years),
were more likely to be male (41% vs. 39%), and had a lower frequency of having > 1 comorbid condition (2.9% vs. 4.2%). They
also had a higher frequency of blood transfusions (41% vs. 19%),
a shorter median length of stay (6 days vs. 8 days), a higher frequency of transfer to a rehabilitation facility (46% vs. 9%), and
a lower frequency of knee infection (0.5% vs. 0.9%) than staged
bilateral TKA patients, but they had higher rate of cardiac complications within 90 days (2.0% vs. 1.7%). Simultaneous patients
had higher in-hospital mortality compared to the second TKA
in staged patients (0.16% vs. 0.06%), but they had similar rates
of in-hospital mortality compared to unilateral patients (0.16%
vs. 0.14%). The cumulative 3-year revision rate was highest in
the unilateral group (2.3%), but it was similar in the staged and
simultaneous bilateral groups (1.4%).
Interpretation — We found important differences between the
outcomes of simultaneous and staged bilateral TKA. Further clarification of outcomes would be best determined in an adequately
powered randomized trial, which would remove the selection bias
inherent in this retrospective study design.
■

Patients who have bilateral knee arthritis and are candidates
for total knee arthroplasty (TKA) may decide between simultaneous or staged bilateral TKA (BTKA). Conflicting outcomes have been reported for simultaneous and staged BTKA.
Simultaneous BTKA has advantages that include bilateral
functional recovery with only a single operation, anesthetic,
hospitalization, recovery period, and analgesia regimen. It
may also lead to better improvements in quality-adjusted life
years, lower costs, and better outcomes (Fu et al. 2013, Odum
et al. 2013). However, several meta-analyses have shown that
simultaneous bilateral TKA may be associated with increased
risks of cardiac complications (Restrepo et al. 2007), pulmonary embolism (Restrepo et al. 2007, Fu et al. 2013), and
death (Restrepo et al. 2007, Hu et al. 2011, Fu et al. 2013) than
staged bilateral TKA. In contrast, other studies have shown
that complications may be more frequent with staged BTKA
than with simultaneous BTKA (Memtsoudis et al. 2009), but
90-day mortality may be similar between unilateral TKA
and simultaneous and staged BTKA (Walmsley et al. 2006).
In addition, it may be difficult to compare simultaneous and
staged BTKA because many patients (37% in one study) may
not undergo the second stage of BTKA due to dissatisfaction
with the first operation, unmet expectations, complications, or
death (Sesen et al. 2015).
In Canada (with 35 million inhabitants), TKA is the most
common type of joint replacement surgery, with 45,830 TKAs
in 2012–2013 that accounted for 57,718 acute-care hospitalizations (Canadian Institute for Health Information 2014). We
compared early outcomes of unilateral TKA, simultaneous
BTKA, and staged BTKA using a large Canadian data set,
including complications, in-hospital mortality, length of hospital stay, discharge disposition, and revision risk.

© 2016 The Author(s). Published by Taylor & Francis on behalf of the Nordic Orthopedic Federation. This is an Open Access article distributed under the terms
of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0)
DOI 10.1080/17453674.2016.1181817
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Patients and methods
The study cohort was selected from the Canadian Hospital
Morbidity Database (HMDB) and contained all the patients
who were discharged after primary TKA between April 2006
(fiscal year 2006–2007) and March 2013 (fiscal year 2012–
2013). The HMDB is a national data holding managed by the
Canadian Institute for Health Information (CIHI) that captures administrative, clinical, and demographic information
on inpatient discharge or transfer from all acute-care hospitals. Primary TKA records were identified using the Canadian
Classification of Health Interventions (CCI) codes 1.VG53.
LA.PN.^ and 1.VG53.LA.PP.^ with status attribute primary
and extent attribute bicompartmental or tricompartmental (Canadian Institute for Health Information, 2015a). The
cohort was subdivided into 3 groups: (1) simultaneous BTKA
(i.e. both TKAs were performed on the same day); (2) staged
BTKA (i.e. both knees were replaced in 2 separate operations within a year); and (3) unilateral TKA (i.e. only 1 TKA
was performed within a year). For staged BTKA, the 1-year
cutoff was selected because patients who had the secondstage TKA performed within 1 year probably had sufficient
bilateral symptoms to initially consider having simultaneous
BTKA (Stefánsdóttir et al. 2008). We excluded unilateral
TKA patients who could have been considered to be staged
BTKA patients because they underwent a contralateral TKA
within 12 months in either the year prior to or the year following the study period.
Explanatory variables of interest included patient age, sex,
comorbidities, and hospital TKA volume quartiles. Comorbidities were defined using the Charlson comorbidity index (Quan
et al. 2005) (Appendix Table A, see Supplementary data) and
grouped by patients who had at least 1 predefined comorbid
condition (index > 0) or no predefined comorbid conditions
(index = 0). Characteristics and outcomes compared between
the groups included blood transfusion during the hospitalization, length of stay in the acute-care facility, complications,
discharge disposition, cumulative percentage revised during
each of the 3 years following the index surgery, and inpatient
mortality. To control for the possible confounding effects of
length of stay, complications were determined by combining
inpatient and outpatient complications. Inpatient complications were defined as complications that presented during the
same hospitalization as the TKA, and included cardiac events
(acute cardiac ischemia, infarction, and arrhythmia), pulmonary embolism, and infection of the TKA (Appendix Table
B, see Supplementary data). Outpatient complications were
defined in the same fashion, and were captured if a patient
was re-admitted to an acute-care hospital (including being
transferred back from a rehabilitation facility where acute
complications are usually not managed) for treatment of any
of these within 90 days of discharge. The 3-year follow-up
data for revision rates were not available for patients who had
revision TKA outside the years included. Due to coding dif-
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ferences, data on pulmonary embolism and re-admission were
not included for patients who were discharged before March
31, 2009. Revision procedures were identified using CCI
codes (1.VG.53 and 1.VP.53) and the status attribute revision.
Except where noted otherwise, outcomes were calculated per
patient (not per operation) to enable patient-specific comparison of complication risk in simultaneous BTKA with cumulative complication risk at both stages of staged BTKA. Thus,
outcomes were reported if they occurred at least once after
each TKA of staged bilateral patients. For discharge disposition, “home setting” might include a seniors’ lodge, supportive
housing, or assistance with meals and/or housekeeping. The
cumulative risk of mortality for either the first or second stage
of staged BTKA could not be accurately estimated because
information on whether an operation was planned as staged
was not available for patients who were intended for staged
BTKA but who died after their first TKA was performed. Thus,
mortality of patients who died after the first stage and before
the second stage of a planned staged surgery was included in
the unilateral TKA group.
Statistics
Data analysis was performed with SAS software version 9.2.
Categorical variables were compared using chi-square test,
and continuous variables were compared using t-test (means)
and Mann-Whitney U test (medians). The p-values that are
reported for outcomes included adjustment for age, sex, preoperative comorbidities, and hospital TKA volume, using
linear regression for continuous outcomes, logistic regression
for binary outcomes, and multinomial logistic regression for
categorical outcomes. The level of significance was set at 0.05
for all tests.
Ethics
The CIHI did not require ethical approval for this analysis of
its data holdings. Data sharing agreements with each Canadian
province, privacy protection mechanisms, and analytical rules
ensure that no individual patient information is identifiable.

Results
During the 7 years of the study, most TKAs performed were
unilateral, and the ratio of simultaneous to staged BTKA was
1:4 (Table 1). Most staged BTKAs (94%) were performed
with at least 3 months between stages. From 2006–2007 to
2012–2013, the annual number of unilateral TKAs increased
by 39% to 37,994, simultaneous BTKAs decreased by 8% to
954, and staged BTKAs increased by 28% to 4,505.
Simultaneous BTKA patients were younger, more often
male, and had a lower frequency of comorbidity than patients
who underwent staged bilateral TKA or unilateral TKA.
Compared to staged bilateral and unilateral TKA, simultaneous BTKAs were more frequently performed in hospitals that
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Table 1. Patient demographics and hospital stay characteristics a
Bilateral b
Characteristic
No. of patients
No. of replacements
Median age (interquartile range)
Sex, male (%)
Comorbidity present (%)
Percentage of operations, by hospital TKA volume
1st quartile (lowest volume)
2nd quartile
3rd quartile
4th quartile (highest volume)
Median total inpatient length of stay (d) d
Discharge disposition (%) e
Transfer to acute care
Transfer to general/special rehabilitation
Transfer to chronic care facility
Home or home setting with support services
Home without support services
Other

Unilateral b
206,771
229,050
68 (61–75)
39
5.09

Simultaneous b
6,349
6,349
64 (58–71)
41
2.87

1st stage

2nd stage

p- value c

67 (60–74)

< 0.001
0.01
< 0.001

25,253
25,253
66 (60–73)
39
4.23

4.39

6
15
27
52
4

2
7
21
70
6

5
14
26
55
8

2.6
10.1
1.2
32.3
53.8
0.1

2.9
46
2.3
22
27
0.2

2.1
8.7
0.9
32
56
0.1

< 0.001
< 0.001

< 0.001

a n = 238,373
b Unilateral: 1

patients. Source: Hospital Morbidity Database, Canadian Institute for Health Information, 2006–2007 to 2012–2013.
knee replaced within 1 year; simultaneous bilateral: both knees replaced during the same operation; staged bilateral: both knees
replaced in separate operations within 1 year.
c Comparison between bilateral TKA groups (simultaneous vs. staged [completed], unless otherwise specified), after adjusting for patient age
at surgery, sex, Charlson-based comorbidity, and TKA volume of facility. Statistical significance was defined by p < 0.05.
d For staged bilateral TKA, the total inpatient length of hospital stay was the sum for both stages, calculated for each patient. Median hospitalization per hospital stay was 4 days/hospitalization.
e Staged bilateral TKA: only the discharge disposition after the second stage was used. The data exclude patients who died during their hospital stay.

were in the highest quartile of TKA volume. Simultaneous
BTKA patients had shorter median inpatient length of stay
than staged BTKA patients, and a different profile of discharge disposition. Simultaneous BTKA patients were more
frequently discharged to a rehabilitation facility than staged
BTKA patients, and most patients who had staged BTKA
(88.2%) were discharged to home or to a home setting (Table
1).
Simultaneous BTKA patients generally had higher rates of
blood transfusion and cardiac complications compared to the
other groups, a higher pulmonary embolism rate than the unilateral group, and a lower frequency of knee infection than
staged patients. We could not detect any difference in in-hospital mortality between the simultaneous BTKA group and the
unilateral TKA group. While the staged group had the lowest
in-hospital mortality rate, it underestimated the true mortality
risk, since it did not include staged patients who died after
their first TKA. The unilateral group had the highest revision
risk at 3 years (Table 2).
Male sex, age > 75 years, and the presence of at least 1
Charlson-based comorbidity all tended to increase the odds
of cardiac complication, pulmonary embolism, knee infection, and in-hospital mortality. Lower TKA volume of a facility appeared to have a protective effect regarding pulmonary
embolism, but it had no clear effect on cardiac complication or
infection (Tables 3 and 4).
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Discussion
Over the 7-year period from April 2006 to March 2013, the
volume of simultaneous BTKAs in Canada dropped, while
the volume of unilateral TKA and staged bilateral TKA both
increased. This trend may in part be explained by concerns
regarding increased mortality risk in patients undergoing
simultaneous BTKA (Stefánsdóttir et al. 2008), which is
also reflected by the selection bias of younger age and fewer
comorbidities in this group.
The observation that patients were older in the staged BTKA
group than in the simultaneous BTKA group (Table 1) is consistent with the results of previous studies (Stefánsdóttir et al.
2008, Odum et al. 2013). Surgeons may offer simultaneous
procedures to younger and healthier patients, thus creating a
selection bias and possibly contributing to better outcomes for
simultaneous BTKA than would otherwise be observed. The
greater proportion of male patients in the simultaneous BTKA
group than in the staged BTKA group (Table 1) is similar to
observations made in several previous studies (Ritter et al.
2003, Barrett et al. 2006, Hutchinson et al. 2006, Stefánsdóttir
et al. 2008, Fu et al. 2013, Odum et al. 2013).
The findings that after simultaneous BTKA, patients had a
higher frequency of discharge to a rehabilitation facility and
a lower frequency of discharge to home than staged BTKA
patients are consistent with those in other studies; however,
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Table 2. Transfusion, complications, in-hospital mortality, and revision risk following unilateral and bilateral TKA
Outcome

Unilateral TKA

Blood transfusion (% of patients)
Inpatient complication rate (% of patients) d
Cardiac complications
Pulmonary embolism
Knee infection

Bilateral TKA
Simultaneous
Staged

13.3

18.6 c

41

p-value a
p-value b
Sim. vs. Staged Sim. vs. Unilat
< 0.001

< 0.001

1.8
1.7 c
0.1
1.1
0.8 c
0.1
N/R g
0.04 c
–e
(< 0.14% but
> 0.06%, n < 5)
Outpatient complication rate (% of patients) (defined as 90-day re-admission for treatment of same) d
Cardiac complications
0.05
N/R g
0.04 c
–e
(< 0.14% but
> 0.05%, n < 5)
Pulmonary embolism
0.14
0.23
0.13 c
–e
Knee Infection
0.6
0.4
0.8 c
0.02
Overall complication rate (inpatient plus outpatient)f (% of patients) d
Cardiac complications
1.4
2.0
1.7 c
0.04
Pulmonary embolism
0.8
1.2
0.9 c
0.12
Knee infection
0.7
0.5
0.9 c
0.02
In-hospital mortality (%) h
0.14
0.16
0.06
0.005
Cumulative revision rate (%) i
Year 1
1.07
0.68
0.63
0.6
Year 2
1.84
1.00
0.96
0.8
Year 3
2.34
1.41
1.37
0.9

< 0.001
0.004
–e

1.3
0.7
0.06

–e
0.2
0.2
< 0.001
0.01
0.3
0.2
< 0.001
< 0.001
< 0.001

a Comparison

between bilateral TKA groups (simultaneous vs. staged). p-value after adjusting for patient age at time of surgery,
sex, Charlson-based comorbidity, and TKA volume of facility. Significance level set at 0.05.
b Comparison between bilateral TKA groups (simultaneous vs. unilateral). p-value after adjusting for patient age at time of surgery, sex, Charlson-based comorbidity, and TKA volume of facility. Significance level set at 0.05.
c Outcomes could be at one or both stages, but they were counted if present at least once.
d Patients discharged before 2009–2010 were excluded due to coding differences (diagnosis cluster was not available).
e p-value not reported due to a possible bias in the logistic regression model estimates arising from the relative rarity of the
observed event.
f If a patient experienced a complication event (cardiac, PE, or infection) in hospital and/or was re-admitted with it within 90 days,
one combined event was coded.
g N/R: not reportable. In accordance with the CIHI privacy policy, cells with counts of 1–4 were suppressed. Suppressed cells
were included in the totals.
h Mortality during hospitalization for TKA. Patients who had planned staged bilateral TKA but had died after the first stage and
before the second stage were included with mortality data for unilateral TKA.
i Does not include patients who had revision outside of the years included.

Table 3. Logistic regression model for combined complication risk (inpatient plus outpatient)

Variable

Cardiac complication
Odds ratio 95%CI
p-value

Group (simultaneous BTKA vs. unilateral TKA)
Sex (male vs. female)
Age group (> 75 vs. < 75)
Charlson-based comorbidity present (yes vs. no)
TKA volume of facility (quartile 1 vs. quartile 4)

1.7
1.3
2.4
3.4
0.8

1.4–2.2
1.2–1.4
2.2–2.6
3.0–3.8
0.7–1.0

< 0.001
< 0.001
< 0.001
< 0.001
0.1

Pulmonary embolism
Odds ratio 95%CI p-value
1.5
0.8
1.4
1.9
0.6

1.1–2.0
0.7–0.9
1.2–1.6
1.5–2.3
0.4–0.8

0.01
< 0.001
< 0.001
< 0.001
< 0.001

Knee infection
Odds ratio 95%CI p-value
0.8
1.6
1.0
1.9
1.0

0.5–1.2
1.4–1.9
0.9–1.2
1.5–2.3
0.7–1.3

0.3
< 0.001
0.6
< 0.001
0.9

Table 4. Multiple logistic regression model for in-hospital mortality risk

Variable

In-hospital mortality
Odds ratio 95%CI p-value

Group (simultaneous vs. unilateral)
Sex (male vs. female)
Age group (> 75 vs. < 75)
Charlson-based comorbidity present (yes vs. no)
TKA volume of facility (quartile 1 vs. quartile 4)
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1.5
1.9
3.6
7.8
0.7

0.8–2.9
1.5–2.4
2.9–4.5
6.2–9.8
0.4–1.2

0.2
< 0.001
< 0.001
< 0.001
1.00

previous studies found that more than one-third of
simultaneous BTKA patients were discharged to inpatient rehabilitation (Lombardi et al. 2001, Bullock et al.
2003, Cushner et al. 2005).
The more than doubled transfusion rate with simultaneous BTKA than with staged BTKA (Table 2) may
have resulted from greater blood loss from the bilateral bone cuts and surgical trauma with simultaneous
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BTKA, which is consistent with the previous observation of
lower blood loss after staged BTKA than after simultaneous
BTKA (Forster et al. 2006). In staged BTKA, a sufficient
interval between stages may enable hematopoiesis to replenish blood loss from the first surgery (Fu et al. 2013). In our
study, > 90% of staged patients waited more than 3 months
between procedures, probably allowing normalization of
hemoglobin before the second procedure. There were no data
available about the volume of blood transfused, but previous
studies have shown a greater likelihood and greater volume of
blood transfusion with simultaneous BTKA than with staged
BTKA (Lombardi et al. 2001, Bullock et al. 2003, Yoon et
al. 2010). However, these results should be interpreted with
caution because blood transfusion practices and reporting
may vary between hospitals and between surgeons (Patil and
Wakankar 2008, Fu et al. 2013).
The cardiac complication rate and pulmonary embolism rate
were highest in the simultaneous bilateral group than in the
other 2 groups, with the exception of the comparison between
pulmonary embolism rates in the simultaneous and staged
groups, which did not reach statistical significance (p = 0.1).
These differences are generally consistent with some metaanalyses that have shown higher risks of cardiac complications
(Restrepo et al. 2007) and pulmonary embolism (Restrepo et
al. 2007, Fu et al. 2013) in simultaneous BTKA than in staged
BTKA. However, the literature is equivocal, with 3 large
meta-analyses not finding evidence for increased cardiac risk
(Hu et al. 2011, Fu et al. 2013, Hussain et al. 2013), and 2
not finding an increased risk of pulmonary embolism (Hu et
al. 2011, Hussain et al. 2013). The reasons for these differences are unclear, but there was a lack of consistency in either
selection of the control group (staged bilateral vs. unilateral)
and/or in controlling for possible confounding factors (such as
age, sex, length of stay, and comorbidities) in both the metaanalyses and the studies they included in their analysis.
The lower frequency of knee infections in the simultaneous BTKA group than in the staged BTKA group (Table 2) is
consistent with results of previous studies (Ritter et al. 1997,
Meehan et al. 2011, Fu et al. 2013). In contrast, other studies have not shown any difference in the frequency of superficial infection (Yoon et al. 2010, Fu et al. 2013). However, a
case-control study involving 72 bilateral simultaneous TKA
patients matched to 144 unilateral TKA patients, based on
age and sex, showed a greater frequency of superficial and
deep infection after simultaneous BTKA than after unilateral
TKA with a minimum of 6 months follow-up. The authors
suggested that contributory factors may have included longer
operating time, more personnel in the operating room, and
rescrubbing, redraping, and changing of instruments between
the simultaneous procedures (Luscombe et al. 2009).
We found a lower revision rate in the simultaneous BTKA
group than in the unilateral TKA group, but we did not detect
a difference in revision rates between the 2 BTKA groups.
A previous meta-analysis and population-based study found
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that simultaneous procedures were associated with a lower
frequency of revision in simultaneous BTKA than in staged
BTKA (Meehan et al. 2011, Fu et al. 2013). However, 4
smaller studies showed no difference in the frequency of
revision between patients who had simultaneous BTKA and
those who had staged BTKA, which is similar to our findings
(Table 2) (Leonard et al. 2003, Ritter et al. 2003, Hutchinson et al. 2006, Taylor et al. 2010). Kreder et al. (2003) have
found higher revision risk to be associated with lower volume
facilities. The higher revision risk in our unilateral group may
simply reflect the fact that a larger proportion of these cases
were performed in lower volume facilities. or simply that
patients who had intended to undergo staged TKA but underwent early revision of the first side and declined the contralateral procedure were captured in the unilateral group.
A clear understanding of true differences in mortality risk
between the 3 groups (unilateral TKA, staged BTKA, and
simultaneous BTKA) is difficult to gain from the literature.
There have been no adequately powered prospective studies,
and the remaining literature consists of either large retrospective studies that were subject to the same types of selection
bias as our work, inadequately powered small prospective
series, or meta-analyses that incorporated these imperfect
studies. Several recent meta-analyses (Restrepo et al. 2007,
Hu et al. 2011, Fu et al. 2013) and large retrospective series
(Memtsoudis et al. 2008, 2009, Stefánsdóttir et al. 2008)
have shown increased in-hospital and 30-day mortality risk
in simultaneous BTKA patients, but some were limited by the
use of only a unilateral TKA comparison group (Restrepo et
al. 2007, Memtsoudis et al. 2008, 2009), or did not adjust for
the confounding effect of comorbidities (Stefánsdóttir et al.
2008). Other meta-analyses are consistent with the results of
the present study, and found no increased risk of in-hospital
mortality in the simultaneous BTKA group (Hussain et al.
2013). The only large case series that attempted to control for
the effect of planned staged BTKA patients who did not proceed to the second side found that there was no increased mortality risk in the simultaneous BTKA group than in the staged
BTKA group (Meehan et al. 2011). While our findings do not
resolve this controversy, we have found similar in-hospital
mortality rates and risk in patients undergoing unilateral TKA
and simultaneous BTKA—similarities that remained when we
adjusted for age, sex, comorbidities, and hospital volume. This
may also reflect the marked decrease in mortality rates in elective TKA patients that has occurred since the 1990s (Lalmohamed et al. 2014). We feel that the statistically significantly
lower mortality rate in the staged group may have been the
result of selection bias in those who proceeded with TKA surgery on the second side, and it should therefore be interpreted
with caution.
The limitations of our study included the absence of information about patients who had intended to have staged BTKA
but deferred the second side. In-hospital mortality in the
staged BTKA group was underestimated, and in the unilat-
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eral group it was probably overestimated because patients
who died after the first stage and before the second stage were
excluded from the staged group and included in the unilateral
group by default. Similarly, the complications and revisions
of those patients who declined to proceed with the planned
second TKA would have been included in the unilateral group,
thus leading to overestimation of these risks in the unilateral
group and to underestimation in the staged group. Mortality
data were limited to in-hospital deaths, and early postoperative mortality may have been underestimated because of the
typically brief postoperative length of hospital stay (median
4–6 days). In addition, the study may have underestimated
the frequency of patients who had comorbidities; the low frequency of patients who had Charlson comorbidity index > 1
(Table 1) may have occurred because several common and
important medical conditions such as diabetes (without complications), previous myocardial infarction, and peripheral
vascular disease had a weight factor of 0 in the index (Table A,
see Supplementary data). However, changing of the 0 weight
factors to 1 for these conditions and re-running the analysis
did not change our findings (data not shown). Another concern may be that a comorbidity is detected only after admission to hospital; however, pre-admission clinics that screen
the patient’s fitness for surgery are ubiquitous across Canada,
and it would be very unusual for a patient to undergo elective surgery without a clinically relevant comorbidity being
identified prior to admission. We also recognize that it was not
possible to adjust for possible confounding factors that were
not captured in our data set, such as body mass index, physical
fitness, or others. Furthermore, comparison of perioperative
care between patient groups was not possible because these
data were not available.
Miscoding is a potential source of error in administrative
databases, but CIHI has a comprehensive data quality program that involves a continuous process of data improvement
(Canadian Institute for Health Information, 2009 and 2015b).
While there are no published data on the accuracy of coding of
total knee replacements, an assessment of coding for hip fracture admissions revealed a positive predictive value (PPV) of
97% (Canadian Institute for Health Information, 2010). This
same data quality assessment found that diagnosis of a postadmission acute myocardial infarction had a PPV of 82%, and
that diagnosis of a post-admission deep venous thrombosis or
pulmonary embolism had a PPV of 84%. Coding of comorbidity level also appeared good, with an overall agreement rate
of 90%. The reported sensitivities of capturing an in-hospital
acute myocardial infarction (68%) and deep venous thrombosis (66%) are lower; however, we have no reason to believe
that there would be any systemic bias in the capture rates
between the 3 groups (Canadian Institute for Health Information, 2010). Another concern might be an artificially low
acute-care hospital length of stay in the simultaneous BTKA
group due to a planned transfer to a rehabilitation facility;
however, the availability of rehabilitation beds in Canada is
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not always predictable and is therefore unlikely to have artificially reduced the length of stay.
In summary, our study has shown important differences
between outcomes of simultaneous BTKA and staged BTKA,
with simultaneous BTKA having a higher frequency of
blood transfusion, a lower median hospital length of stay, a
higher proportion of discharge to a rehabilitation facility, a
lower 90-day risk of knee infection, and higher 90-day risk
of cardiac complication. Simultaneous BTKA patients appear
to have similar rates of in-hospital mortality compared to
patients undergoing unilateral TKA, but a lower risk of revision at 3 years. Generally speaking, patients having simultaneous BTKA were younger, were more often male, had a lower
frequency of preoperative comorbidities, and more often had
surgery in a high-volume center than patients having staged
BTKA, which possibly contributed to selection bias in this
study. Further investigation of outcomes would best be done
in an adequately powered randomized trial.
Supplementary data
Tables A and B are available on the Acta Orthopaedica website at www.actaorthop.org, identification number 9269.
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